Abbott Fund
Abbott Fund
Abbott Fund
ScienceEd

Abbott Global

Neglected Diseases in Haiti

Share | print

Combating Lymphatic Filariasis

The Abbott Fund is partnering with the University of Notre Dame in its fight to defeat lymphatic filariasis, among the world’s most debilitating infectious illnesses.

RESULTS
System.ArgumentException: Parameter is not valid. at System.Drawing.Bitmap..ctor(Int32 width, Int32 height, PixelFormat format) at System.Drawing.Bitmap..ctor(Image original, Int32 width, Int32 height) at AWS.Imaging.ImageResizer.ResizeAndSaveImage(String imagePath, String resizedImagePath, Int32 maxImageWidth, Int32 maxImageHeight) at AWS.Web.UI.WebControls.ImageDisplay.get_ImageUrl()
Overview
Lymphatic filariasis (LF) is a mosquito-borne disease caused by the transmission of threadlike parasitic worms that do devastating damage to the human lymphatic system. A disease commonly recognized as a neglected tropical disease, LF afflicts 120 million people globally. Over the past 10 years, the University of Notre Dame, Haiti’s Ministry of Health and the Gates Foundation have led the development and coordination of a program aimed at eliminating LF. Now, with an additional $2.6 million grant through 2013 from the Abbott Fund, Notre Dame is taking its learnings to build and expand its LF and nutrition activities while providing community income-generating opportunities. The grant supports scaling up local production of salt fortified with an antifilarial drug, diethylcarbamazine citrate (DEC), and iodine, plus a mass drug administration campaign in Port-au-Prince and the country’s central region, as well as enhanced monitoring and evaluation in the north.
Download PDF of this Project

05/14/2012
ADDITIONAL PROJECTS

Copyright © 2006, 2012 Abbott Fund. Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.